Tryp Therapeutics

Tryp Therapeutics is a pharmaceutical company focused on identifying and developing clinical-stage compounds for the treatment of orphan diseases and other conditions with unmet medical needs. Tryp's Psilocybin-For-Neuropsychiatric Disorders (PFN™) program is dedicated to developing synthetic psilocybin as a novel therapeutic for chronic pain and eating disorder indications.